FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Gabapentin Capsules
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Epic Pharmaceuticals (New 05/03/2018)

Company Contact Information:
718-276-8607

Presentation Posting Date Related Information
Gabapentin Capsules 100 mg 30 count (NDC 42806-509-30) 05/03/2018 This discontinuation is due to a business decision.
Gabapentin Capsules 100 mg 100 count (NDC 42806-509-01) 05/03/2018 This discontinuation is due to a business decision.
Gabapentin Capsules 100 mg 1000 count (NDC 42806-509-10) 05/03/2018 This discontinuation is due to a business decision.
Gabapentin Capsules 300 mg 30 count (NDC 42806-510-30) 05/03/2018 This discontinuation is due to a business decision.
Gabapentin Capsules 300 mg 100 count (NDC 42806-510-01) 05/03/2018 This discontinuation is due to a business decision.
Gabapentin Capsules 300 mg 1000 count (NDC 42806-510-10) 05/03/2018 This discontinuation is due to a business decision.
Gabapentin Capsules 400 mg 30 count (NDC 42806-511-30) 05/03/2018 This discontinuation is due to a business decision.
Gabapentin Capsules 400 mg 100 count (NDC 42806-511-01) 05/03/2018 This discontinuation is due to a business decision.
Gabapentin Capsules 400 mg 1000 count (NDC 42803-511-10) 05/03/2018 This discontinuation is due to a business decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English